Steven Hyman, M.D.
Director of the Stanley Center for Psychiatric Research
Core Faculty member at the Broad Institute of Harvard and MIT
Steven E. Hyman, M.D. is Harvard University Distinguished Service Professor of Stem Cell and Regenerative Biology and Director of the Stanley Center for Psychiatric Research and a Core Faculty member at the Broad Institute of Harvard and MIT. From 2001 to 2011, he served as Provost of Harvard University, the University’s chief academic officer. As Provost he had a special focus on developing collaborative initiatives in the sciences and engineering spanning multiple disciplines and institutions. From 1996 to 2001, he served as director of the US National Institute of Mental Health (NIMH), where he emphasized investment in neuroscience and emerging genetic technologies. He also initiated a series of large practical clinical trials, including an emphasis on children, a population about which little was known.
Hyman is member of the National Academy of Medicine (NAM). From 2012-2018 he chaired the National Academies of Sciences, Engineering, and Medicine Forum on Neuroscience and Nervous System Disorders, which brings together industry, government, academia, patient groups, and foundations. From 2001-2016 he served as Editor of the Annual Review of Neuroscience. He has been President of the Society for Neuroscience (2015), of the American College of Neuropsychopharmacology (ACNP; 2018) and was founding President of the International Neuroethics Society.
Hyman serves as a Board vice-chair the Charles A. Dana Foundation and as a Director of the Charles Revson Foundation. He is a Director of two biotechnology companies, Voyager Therapeutics and Q State Biosciences and serves on multiple Scientific Advisory Boards including Janssen, BlackThorn, and F-Prime. He is a Fellow of the American Academy of Arts and Sciences, a Fellow of the American Association for the Advancement of Science, and a Distinguished Life Fellow of the American Psychiatric Association. Hyman received his B.A. summa cum laude from Yale College, an M.A. from the University of Cambridge, which he attended as a Mellon fellow, and an M.D. cum laude from Harvard Medical School.